Pulse Biosciences, Inc. PLSE
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 101.62M | 68.32M | 80.74M | 95.21M | 106.35M |
| Total Receivables | 122.00K | 157.00K | 274.00K | 15.00K | -- |
| Inventory | 236.00K | 206.00K | 136.00K | 57.00K | 51.00K |
| Prepaid Expenses | 3.72M | 2.45M | 2.28M | 1.87M | 1.76M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 105.70M | 71.13M | 83.42M | 97.16M | 108.16M |
|
|
|||||
| Total Current Assets | 105.70M | 71.13M | 83.42M | 97.16M | 108.16M |
| Net Property, Plant & Equipment | 6.45M | 6.72M | 7.06M | 7.37M | 7.72M |
| Long-term Investments | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M |
| Goodwill | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M |
| Total Other Intangibles | 222.00K | 408.00K | 575.00K | 741.00K | 907.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 403.00K | 575.00K | 691.00K | 705.00K | 677.00K |
| Total Assets | 115.56M | 81.62M | 94.54M | 108.77M | 120.25M |
|
|
|||||
| Total Accounts Payable | 2.83M | 2.76M | 2.78M | 2.98M | 2.74M |
| Total Accrued Expenses | 6.46M | 5.41M | 3.58M | 5.20M | 4.78M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.69M | 1.63M | 1.57M | 1.52M | 1.46M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.98M | 9.80M | 7.92M | 9.70M | 8.98M |
|
|
|||||
| Total Current Liabilities | 10.98M | 9.80M | 7.92M | 9.70M | 8.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.09M | 5.53M | 5.96M | 6.37M | 6.79M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 16.06M | 15.32M | 13.88M | 16.07M | 15.76M |
|
|
|||||
| Common Stock & APIC | 606.02M | 548.16M | 543.94M | 538.54M | 530.95M |
| Retained Earnings | -506.52M | -481.86M | -463.28M | -445.85M | -426.46M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 99.50M | 66.30M | 80.66M | 92.69M | 104.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 99.50M | 66.30M | 80.66M | 92.69M | 104.49M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 99.50M | 66.30M | 80.66M | 92.69M | 104.49M |
|
|
|||||